Claudia Bellofiore
6PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 18, 2026
Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real-world patients.Claudia Bellofiore, Marco Basset, Mario Nuvolone
|Mar 25, 2025
Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study.Claudia Bellofiore, Marco Basset, Giuseppe Damiano Sanna
|Feb 20, 2025
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study.Amy Song, George Mellgard, Claudia Bellofiore
|Jun 02, 2024
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.Claudia Bellofiore, Pietro Benvenuti, Roberto Mina
|Mar 21, 2024
Development and Validation of Staging Systems for AA Amyloidosis.Marco Basset, Stefan O Schönland, Laura Obici
|Jun 30, 2022
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival.Marco Basset, Paolo Milani, Andrea Foli
Pageof 1
Frequent Collaborators
4 joint publications
Marco Basset
2 joint publications
Andrea Foli
2 joint publications
Giovanni Palladini
2 joint publications
Giampaolo Merlini
1 joint publications
Stefan O Schönland
1 joint publications
Laura Obici
1 joint publications
Eloisa Riva
1 joint publications
Tobias Dittrich
1 joint publications
Paolo Milani
1 joint publications
Virginia Valeria Ferretti
